» Articles » PMID: 34965882

Estimating Proportion of Days Covered (PDC) Using Real-world Online Medicine Suppliers' Datasets

Overview
Date 2021 Dec 30
PMID 34965882
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The proportion of days covered (PDC) is used to estimate medication adherence by looking at the proportion of days in which a person has access to the medication, over a given period of interest. This study aimed to adapt the PDC algorithm to allow for plausible assumptions about prescription refill behaviour when applied to data from online pharmacy suppliers.

Methods: Three PDC algorithms, the conventional approach (PDC1) and two alternative approaches (PDC2 and PDC3), were used to estimate adherence in a real-world dataset from an online pharmacy. Each algorithm has different denominators and increasing levels of complexity. PDC1, the conventional approach, is the total number of days between first dispensation and a defined end date. PDC2 counts the days until the end of supply date. PDC3 removes from the denominator specifically defined large gaps between refills, which could indicate legitimate reasons for treatment discontinuation. The distribution of the three PDCs across four different follow-up lengths was compared.

Results: The dataset included people taking ACE inhibitors (n = 65,905), statins (n = 100,362), and/or thyroid hormones (n = 30,637). The proportion of people taking ACE inhibitors with PDC ≥ 0.8 was 50-74% for PDC1, 81-91% for PDC2, and 86-100% for PDC3 with values depending on drug and length of follow-up. Similar ranges were identified in people taking statins and thyroid hormones.

Conclusion: These algorithms enable researchers and healthcare providers to assess pharmacy services and individual levels of adherence in real-world databases, particularly in settings where people may switch between different suppliers of medicines, meaning an individual supplier's data may show temporary but legitimate gaps in access to medication. Accurately identifying problems with adherence provides the foundation for opportunities to improve experience, adherence and outcomes and to reduce medicines wastage. Research with people taking medications and prescribers is required to validate the algorithms' assumptions.

Citing Articles

One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study.

Kang M, Sohn J, Cha M, Kim Y, Hong Y, Im H J Clin Med. 2025; 14(3).

PMID: 39941406 PMC: 11818848. DOI: 10.3390/jcm14030734.


The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.

Berthelot W, Sirois C, Julien A, Amiable N, Bessette L, Desaulniers P Rheumatol Int. 2025; 45(3):44.

PMID: 39921727 DOI: 10.1007/s00296-025-05804-8.


Medication Management Initiatives Using Wearable Devices: Scoping Review.

Iino H, Kizaki H, Imai S, Hori S JMIR Hum Factors. 2024; 11:e57652.

PMID: 39602520 PMC: 11612519. DOI: 10.2196/57652.


Approach to Estimating Adherence to Heart Failure Medications Using Linked Electronic Health Record and Pharmacy Data.

Blecker S, Zhao Y, Li X, Kronish I, Mukhopadhyay A, Stokes T J Gen Intern Med. 2024; .

PMID: 39585579 DOI: 10.1007/s11606-024-09216-5.


Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.

Klimchak A, Signorovitch J, Innis B, Laverty C, Gooch K Adv Ther. 2024; 42(1):523-536.

PMID: 39527337 PMC: 11782370. DOI: 10.1007/s12325-024-03044-z.


References
1.
Vrijens B, de Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T . A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5):691-705. PMC: 3403197. DOI: 10.1111/j.1365-2125.2012.04167.x. View

2.
Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P . Assessing medication adherence: options to consider. Int J Clin Pharm. 2013; 36(1):55-69. DOI: 10.1007/s11096-013-9865-x. View

3.
Horne R, Chapman S, Parham R, Freemantle N, Forbes A, Cooper V . Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; 8(12):e80633. PMC: 3846635. DOI: 10.1371/journal.pone.0080633. View

4.
Peterson A, Nau D, Cramer J, Benner J, Gwadry-Sridhar F, Nichol M . A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007; 10(1):3-12. DOI: 10.1111/j.1524-4733.2006.00139.x. View

5.
Aldughayfiq B, Sampalli S . Digital Health in Physicians' and Pharmacists' Office: A Comparative Study of e-Prescription Systems' Architecture and Digital Security in Eight Countries. OMICS. 2020; 25(2):102-122. PMC: 7888294. DOI: 10.1089/omi.2020.0085. View